Study to Evaluate Cerebral AneurysmFlow Results in Occlusion

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions
Intracranial Aneurysm
Interventions
DEVICE

AneurysmFlow

AneurysmFlow R1.0 is an approved (CE labeled, cleared in US, Canada and Argentina), software tool intended to provide relevant information on the blood flow in a cerebral aneurysm and its parent artery based on angiography. It provides color coded and vector field representation of a digital subtraction angiography (DSA). It can quantify blood flow rates in the artery based on DSA and 3-D Rotational Angiogram (3DRA) data. It can visualize blood flow patterns in an aneurysm based on DSA data. Specifically, it calculates the Mean Aneurysm Flow Amplitude (MAFA) ratio to measure the volumetric flow rate quotient before and after Flow Diverter Stent (FDS) implantation in the region of interest. It is manufactured by Philips Medical Systems B.V., a Philips Healthcare company.

Trial Locations (4)

32207

Baptist Health, Jacksonville

01655

UMass Medical Center, Worcester

C1428 CABA

ENERI, Buenos Aires

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

Philips Clinical & Medical Affairs Global

INDUSTRY

NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion | Biotech Hunter | Biotech Hunter